May's Reader Favorites
In case you missed them, here are our top stories from May 2023. This month’s best stories cover a wide variety of topics like upcoming therapies, new research findings, and more.
1. FDA Clears Beta Bionics' iLet Bionic Pancreas – No Carb Counting Required
Beta Bionics has received FDA clearance for its insulin-only iLet Bionic Pancreas, an automated insulin delivery system that eliminates the need for carbohydrate counting.
2. What I Eat As a Diabetes Expert, Dietitian, and Strength Coach with Type 1 Diabetes
Ben Tzeel, a registered dietitian and strength coach who has lived with type 1 diabetes for over 20 years, discusses his daily eating habits and what others with diabetes should know.
3. Non-Invasive Glucose Monitoring: Hope or Hype?
For years, people with diabetes have sought out an accurate way to measure glucose without the need for fingersticks or fluid samples. Here’s a look at the latest in research and development of non-invasive glucose monitoring devices.
4. Gut Microbiome and Optimal Health: Unleashing the Power of Probiotics and Fiber-Rich Foods
What is the gut microbiome? There are five well-known organs that humans need to survive – the heart, lungs, brain, kidneys, and liver. However, some studies indicate there is a sixth “organ” that is imperative for human survival: the gut microbiome.
5. Trial Results Position Mounjaro for Weight Loss Drug Approval
Eli Lilly’s SURMOUNT-2 trial clinical trial results show substantial weight loss in people with type 2 diabetes taking Mounjaro (tirzepatide) at high doses, positioning the injectable drug for FDA approval as an obesity drug.
